India’s First Homegrown CAR-T Cell Therapy Shows 73% Success Against Cancer
20 Mar 2025
India has made a significant stride in cancer treatment with the development of its first indigenous CAR-T cell therapy, NexCAR19. This groundbreaking therapy, tested on patients suffering from B-cell leukaemia and lymphoma—two rare blood cancers affecting the bone marrow and lymphatic system—has shown an impressive 73% success rate in clinical...
Read More
